Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 22 October 2026
      Europe has the science on Alzheimer’s disease. Now it needs a plan to deliver it
 
 
Read the full article here.
 

As new diagnostic tests and treatments have changed what an Alzheimer's disease diagnosis can mean, patients, doctors, MEPs and industry warn that limited funding, health systems lagging behind innovation and missing political will could still leave people waiting.

Read more →
 
 
      What is the impact of overweight and obesity in Germany?

A recent report by the Office of Health Economics, commissioned by EFPIA, shows that elevated BMI is associated with 278,000 deaths and almost 8 million years of healthy life lost annually across eight European countries. The economic costs are equally significant, accounting for 0.6% to 1.4% of national GDP.

Germany has the largest total annual burden, at €55.2 billion.

Find out more in the report and the infographic.

 
 
      The IPHA Podcast: Safe Hearts, Stronger Nations: Turning EU Ambition into Irish Action

Hosted by Professor Michal Vrablik, Professor of Internal Medicine at Charles University and an architect of the Czech National Cardiovascular Plan, and David Kelly, Operations Manager at Global Heart Hub, Chair of Heart and Stroke Voice Ireland, and a congenital heart valve disease patient, the discussion moves between policy and lived experience.

Listen to the podcast here.

 
 
      IHI Forum 2026 - Translating research into long-term impact

How can research partnerships deliver lasting impact for patients and Europe? Watch the video message from Jean-Christophe Tellier, Chief Executive Officer of UCB, presented at the IHI Forum 2026.

 
 
 
      Events
 
 
11 NOV 2026
  Health Means Wealth conference Prague, Czech Republic

The Health Means Wealth conference will explore how investing in health and innovation can strengthen health system...

Learn more →
 
 
 
17 NOV 2026
  Europe's Life Sciences Competitiveness Agenda - Innovation, investment and global... Hybrid

Organised by Rapporteur, this event will explore how Europe can strengthen its life sciences competitiveness and improve...

Learn more →
 
 
      What we are reading
How can the health sector be a driver of economic competitiveness in Europe? 19 October 2026  (European Observatory on Health Systems and Policies) Read more →
Belgian PM calls for pharma shield after GSK job cuts 16 October 2026  (Rapporteur) Read more →
Life Sciences Declaration: Take action now to safeguard health, prosperity and strategic autonomy... 04 October 2026  (pharma.be) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe